Xue F S, Liu J H, Liao X, Tong S Y, Li L, Zhang R J, An G, Luo L K
Department of Anesthesia, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Anesth Analg. 1998 Apr;86(4):861-6. doi: 10.1097/00000539-199804000-00034.
To evaluate the influence of acute isovolemic hemodilution on the dose-response and time course of action of vecuronium, we studied 60 adult patients with and without hemodilution during surgery. The patients with hemodilution underwent major elective plastic surgery with an anticipated surgical loss of more than 600 mL. Anesthesia was induced with thiopental 4-6 mg/kg and fentanyl 2-4 microg/kg i.v. and was maintained with 60% nitrous oxide in oxygen. Further increments of thiopental 2 mg/kg or fentanyl 2 microg/kg were given as required. Acute isovolemic hemodilution in the hemodilution group was induced by drainage of venous blood and an i.v. infusion of lactated Ringer's solution and 6% dextran, during which hematocrit and hemoglobin decreased from 45.7% to 26.2% and from 148.5 g/L to 90.2 g/L, respectively. Neuromuscular function was assessed mechanomyographically with train-of-four stimulation at the wrist every 12 s, and the percent depression of T1 response was used as the study parameter. The dose-response relationships of vecuronium in the two groups were determined by using the cumulative dose-response technique. The results showed that during hemodilution, the dose-response curve of vecuronium was shifted to the left in a parallel fashion, and the potency of vecuronium was increased. There were significant differences in the 50%, 90%, and 95% effective doses between the two groups. After the i.v. administration of vecuronium 80 microg/kg, vecuronium-induced neuromuscular block was significantly longer in the patients with hemodilution than in the control patients. The duration of peak effect, clinical duration, recovery index, and total duration in the hemodilution patients were significantly different from those in the control patients. We conclude that hemodilution induces significant changes in the pharmacodynamics of vecuronium.
We found that patients with hemodilution were 20% more sensitive to vecuronium and had a longer duration of action after the administration of the same dose than the controls. This should be taken into account when vecuronium is used as a muscle relaxant during acute hemodilution.
为评估急性等容血液稀释对维库溴铵剂量反应及作用时效的影响,我们研究了60例手术中的成年患者,其中部分患者进行了血液稀释。进行血液稀释的患者接受了预计手术失血超过600 mL的大型择期整形手术。静脉注射硫喷妥钠4 - 6 mg/kg和芬太尼2 - 4 μg/kg诱导麻醉,并用60%氧化亚氮-氧气维持。根据需要进一步静脉注射硫喷妥钠2 mg/kg或芬太尼2 μg/kg。血液稀释组通过静脉放血及静脉输注乳酸林格液和6%右旋糖酐诱导急性等容血液稀释,在此期间,血细胞比容和血红蛋白分别从45.7%降至26.2%,从148.5 g/L降至90.2 g/L。每隔12秒在腕部采用四个成串刺激通过肌电图评估神经肌肉功能,并将T1反应的抑制百分比作为研究参数。采用累积剂量反应技术确定两组维库溴铵的剂量反应关系。结果显示,血液稀释期间,维库溴铵的剂量反应曲线平行左移,维库溴铵的效价增加。两组之间的50%、90%和95%有效剂量存在显著差异。静脉注射80 μg/kg维库溴铵后,血液稀释患者维库溴铵诱导的神经肌肉阻滞明显长于对照组患者。血液稀释患者的峰值效应持续时间、临床持续时间、恢复指数和总持续时间与对照组患者显著不同。我们得出结论,血液稀释可引起维库溴铵药效学的显著变化。
我们发现血液稀释患者对维库溴铵的敏感性比对照组高20%,并且在给予相同剂量后作用持续时间更长。在急性血液稀释期间使用维库溴铵作为肌肉松弛剂时应考虑到这一点。